En måned efter den fjerde dosis viste alle vaccinerede beskyttende niveauer af anti- HB- antistoffer og var sero- positive for anti- HAV- antistoffer.
One month after the fourth dose, all vaccinees demonstrated seroprotective levels of anti-HBs antibodies and were seropositive for anti-HAV antibodies.